Posts by Sandra Ansanay-Alex
Givaudan Invests USD 110 Million in New Fragrance Facility in Mexico
Givaudan has announced a strategic investment of USD 110 million to build a new fragrance compounding facility in Pedro Escobedo, Mexico, reinforcing its presence in Latin America and supporting its long-term growth ambitions under the company’s 2030 strategy. The new site will operate under Givaudan’s “in the region, for the region” supply model, bringing production…
Read MoreTech4Eva Concludes After Five Years of Advancing Women’s Health Innovation
After five years of fostering innovation in women’s health, the Tech4Eva programme—co-founded by EPFL Innovation Park and Groupe Mutuel—will officially come to an end in 2026. Launched as a pioneering Femtech accelerator, Tech4Eva has grown into an internationally recognized exchange platform connecting entrepreneurs, researchers, corporates, and healthcare professionals with a shared mission: improving women’s health…
Read MoreProf. Bloch and Prof. Courtine Honored with the Queen Elizabeth Prize for Engineering 2026
The Queen Elizabeth Prize for Engineering 2026 has been awarded to Jocelyne Bloch, Head of Neurosurgery at the CHUV and professor at the Université de Lausanne, together with Grégoire Courtine, professor at the EPFL. The award recognizes their pioneering work in developing electronic spinal cord stimulation technologies that restore motor functions in people with spinal…
Read MoreEPFL and UNIL Co-Lead Three New National Research Poles for 2026–2029
For the 2026–2029 period, Switzerland has selected three major National Research Poles (PRN/NCCR) involving scientists from the Université de Lausanne and EPFL. These ambitious programmes address some of the most fundamental and urgent scientific challenges: the origins of life, the fight against childhood cancer, and separation sciences. Genesis: understanding the origins of lifeCo-hosted by the…
Read MoreIlmac – Start-Up Area
Start-ups and newcomers are welcome to participate at Ilmac 2026 in Lausanne (23 – 24 September 2026 – Beaulieu) with a discount price. They can also join the BioAlps’ area. Ilmac is a the largest fair for the chemical and life science industry in Western Switzerland, with more than 3,000 visitors over 2 days. Start-ups…
Read MorePfizer Prize: HUG, UNIL and UNIFR Researchers Awarded
Three Swiss Health Valley research projects have been awarded the Prix Pfizer de la recherche biomédicale 2026, showcasing innovation across cancer immunotherapy, digital health, and personalized medicine. Each project received a CHF 20,000 grant. Personalized cancer vaccine – HUGA research team led by Nicolas Mach, together with Rémi Vernet and Eugenio Fernandez at the HUG…
Read MoreORamaVR Secures $4.5M Late-Seed Funding to Lead theComputational Medical XR Revolution
ORamaVR, the Athens and Geneva-based company the pioneering Computational Medical Extended Reality (CMXR) platform, announced the successful close of a $4.5M seed funding round led by Big Pi Ventures and with additional capital provided by Evercurious VC, both Grece-based technology focused venture capital funds. The funds will be used to expand the company’s product development…
Read MoreMPC Therapeutics launches MitoStem™ to boost CAR-T Cell Durability
The Geneva-based biotech company announces the commercial launch of MitoStem™, a novel T-cell quality enhancer designed to improve the durability and effectiveness of CAR-T therapies through mitochondrial metabolic reprogramming. MitoStem™ increases the proportion of stem cell memory T cells (Tscm), a key immune cell subtype strongly linked to long-lasting therapeutic responses. By reprogramming cellular metabolism,…
Read MoreBioAlps Networking Day 2026
Join the Swiss Health Valley 🇨🇭 community for the BioAlps Networking Day 2026 on 19 November at Beaulieu Lausanne BioAlps’ annual flagship event attracts each year around 350 key players from the Swiss Health Valley🇨🇭 region: representatives from academia, startups, government, and media gather to share the latest trends in life sciences and connect with…
Read MoreSamanTree Medical secured €20 million in financing from the European Investment Bank (EIB)
SamanTree Medical, a European leader in surgical imaging innovation, has secured €20 million in financing from the European Investment Bank (EIB). This financing will support the continued development and commercialisation of the Histolog® Scanner in Europe and the United States. This transaction is supported by InvestEU, the EU’s flagship program to mobilize more than €372…
Read More